Moreover, fecal microbial transplantation from humans to germ-free mice favored the outgrowth of B. fragilis with anticancer properties in melanoma-bearing mice treated with CTLA-4 antibodies, demonstrating that these bacteria can synergize with checkpoint blockade therapy [59]. This evidence concerns the gene CTLA4 and melanoma.